FFAR4 and type 2 diabetes mellitus: Our findings demonstrate a robust relationship between decreased GPR‐120 levels and the presence of DN, thus reinforcing the notion that GPR‐120 might be a clinically meaningful biomarker for evaluating metabolic and renal risks among individuals with type 2 diabetes.